{
  "type": "hyp",
  "text": "We generated monoclonal antibodies that target FGF-BP protein and used them as a tool to evaluate frequency and pattern of FGF-BP expression during the malignant progression of pancreas and colorectal carcinoma in archival tissue samples.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "We",
        "monoclonal antibodies",
        "FGF-BP protein",
        "them",
        "a tool",
        "frequency",
        "pattern",
        "FGF-BP expression",
        "the malignant progression",
        "pancreas",
        "colorectal carcinoma",
        "archival tissue samples"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What did the researchers use to determine the frequency and pattern of FGF-BP expression?",
          "What did we generate that target FGF-BP protein?",
          "What protein did the antibodies target?",
          "What did we use to evaluate the frequency and pattern of FGF-BP expression?",
          "What did we use the antibodies for?",
          "What did the antibodies used to evaluate?",
          "What did the antibodies used to evaluate?",
          "What did the antibodies used to evaluate in archival tissue samples?",
          "What did the antibodies used to evaluate the frequency and pattern of FGF-BP expression during?",
          "What part of the body is affected by the FGF-BP protein?",
          "What type of cancer is a common cause of death for archival tissue samples?",
          "Where did we generate antibodies that target FGF-BP protein?"
        ]
      }
    }
  },
  "asked": {
    "What did the researchers use to determine the frequency and pattern of FGF-BP expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "monoclonal antibodies",
        "answerability": 0.9970032572746277,
        "ground_truth": {
          "We": {
            "bertscore": 0.5675885677337646,
            "f1": 0
          }
        }
      }
    },
    "What did we generate that target FGF-BP protein?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "monoclonal antibodies",
        "answerability": 0.9976310133934021,
        "ground_truth": {
          "monoclonal antibodies": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What protein did the antibodies target?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "FGF-BP",
        "answerability": 0.9964698553085327,
        "ground_truth": {
          "FGF-BP protein": {
            "bertscore": 0.8728506565093994,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "What did we use to evaluate the frequency and pattern of FGF-BP expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "monoclonal antibodies",
        "answerability": 0.9962117075920105,
        "ground_truth": {
          "them": {
            "bertscore": 0.667904257774353,
            "f1": 0
          }
        }
      }
    },
    "What did we use the antibodies for?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "to evaluate frequency and pattern of FGF-BP expression during the malignant progression of pancre",
        "answerability": 0.9896517395973206,
        "ground_truth": {
          "a tool": {
            "bertscore": 0.5808832049369812,
            "f1": 0
          }
        }
      }
    },
    "What did the antibodies used to evaluate?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "frequency and pattern of FGF-BP expression",
        "answerability": 0.9956886172294617,
        "ground_truth": {
          "frequency": {
            "bertscore": 0.6844313740730286,
            "f1": 0.2857142857142857
          },
          "pattern": {
            "bertscore": 0.6989353895187378,
            "f1": 0.2857142857142857
          }
        }
      }
    },
    "What did the antibodies used to evaluate in archival tissue samples?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "frequency and pattern of FGF-BP expression",
        "answerability": 0.9691500663757324,
        "ground_truth": {
          "FGF-BP expression": {
            "bertscore": 0.8794811964035034,
            "f1": 0.5
          }
        }
      }
    },
    "What did the antibodies used to evaluate the frequency and pattern of FGF-BP expression during?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "the malignant progression of pancreas and colorectal carcinoma",
        "answerability": 0.9925847053527832,
        "ground_truth": {
          "the malignant progression": {
            "bertscore": 0.8102005124092102,
            "f1": 0.4444444444444445
          }
        }
      }
    },
    "What part of the body is affected by the FGF-BP protein?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "pancreas",
        "answerability": 0.9674790501594543,
        "ground_truth": {
          "pancreas": {
            "bertscore": 0.9999996423721313,
            "f1": 1.0
          }
        }
      }
    },
    "What type of cancer is a common cause of death for archival tissue samples?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0013058781623840332,
        "ground_truth": {
          "colorectal carcinoma": {
            "bertscore": 0.6445000171661377,
            "f1": 0
          }
        }
      }
    },
    "Where did we generate antibodies that target FGF-BP protein?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "archival tissue samples",
        "answerability": 0.9498401880264282,
        "ground_truth": {
          "archival tissue samples": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    }
  }
}